The Journal of infectious diseases · 2026
Tearing Down the Wall: emu-miR-745-3p in Echinococcus multilocularis Exosomes Attenuates Host Liver Fibrosis to Permit Invasive Lesion Development.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yang Ning, Zhang Hongbin, Shi Bowen, Xue Junlong, Chu Jin, Zhang Xue, Li Liang, Liu Hui, Lü Guodong, Bi Xiaojuan, Lin Renyong
Аннотация
BACKGROUND: Alveolar echinococcosis (AE), caused by Echinococcus multilocularis (E. multilocularis), exhibits tumor-like, invasive growth in the liver. Unlike cystic echinococcosis, AE lesions are bordered by loose fibrosis, not a dense capsule. How the parasite weakens this host fibrotic response remians unknown.
METHODS: We identified functional miRNAs in parasite-derived exosomes via small RNA sequencing and multi-step screening, validated them using bioinformatics, luciferase assays, and in vitro studies in hepatic stellate cell studies (HSCs) and inhibited the target in vivo with AAV6-delivered TuD RNA in mice.
RESULTS: Exosomal emu-miR-745-3p from E. multilocularis targets DPP4 in HSCs, suppressing their activation and reducing fibrotic markers (α-SMA, COL1A1, TIMP1). In vivo inhibition of this miRNA increased perilesional fibrosis and capsule thickness, and decreased parasite burden.
CONCLUSIONS: E. multilocularis employs exosomal emu-miR-745-3p to attenuate host fibrotic encapsulation, facilitating invasive growth. The emu-miR-745-3p/DPP4 axis is a critical determinant of AE pathology and a potential target for novel anti-fibrotic therapeutics.
METHODS: We identified functional miRNAs in parasite-derived exosomes via small RNA sequencing and multi-step screening, validated them using bioinformatics, luciferase assays, and in vitro studies in hepatic stellate cell studies (HSCs) and inhibited the target in vivo with AAV6-delivered TuD RNA in mice.
RESULTS: Exosomal emu-miR-745-3p from E. multilocularis targets DPP4 in HSCs, suppressing their activation and reducing fibrotic markers (α-SMA, COL1A1, TIMP1). In vivo inhibition of this miRNA increased perilesional fibrosis and capsule thickness, and decreased parasite burden.
CONCLUSIONS: E. multilocularis employs exosomal emu-miR-745-3p to attenuate host fibrotic encapsulation, facilitating invasive growth. The emu-miR-745-3p/DPP4 axis is a critical determinant of AE pathology and a potential target for novel anti-fibrotic therapeutics.